在心力衰竭中尿素水平的预后价值与恢复的喷射部分
Nandan Kodur1, Paul Gunsalus2, Alex Milinovich2
1Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, OH (N.K., J.E.D., W.H.W.T.).
Circulation. Heart failure
|November 3, 2025
概括
在左心室喷射分数 (LVEF) 恢复时的N-终端亲B型尿素 (NT-proBNP) 水平预测心力衰竭 (HF) 患者的预后. 较高的NT-proBNP表明LVEF复发或不良事件的风险更高.
科学领域:
- 心脏病学 心脏病学
- 生物标志物 生物标志物
- 心脏衰竭研究研究
背景情况:
- 在心力衰竭 (HF) 患者的预后中缺乏强大的临床标志物,患者的左心室喷射分数 (LVEF) 已恢复.
- 需要确定这种患者群体中不良结果的预测因素.
研究的目的:
- 为了调查在LVEF恢复时测量的N-终端亲B型尿素 (NT-proBNP) 是否预测HF患者的预后.
- 评估NT-proBNP作为LVEF复发和复合结果的独立预测因素.
主要方法:
- 对3935名高发烧患者的回顾性队列研究,这些患者的LVEF已恢复 (LVEF≤40%至≥50%).
- 在LVEF恢复时分析NT-proBNP水平.
- 卡普兰-梅尔分析和多变量考克斯回归来评估LVEF复发和复合结局 (HF住院或因任何原因死亡).
主要成果:
- 在LVEF恢复时的NT-proBNP水平与预后相反相关.
- 较高的NT-proBNP水平独立预测了LVEF复发风险增加和剂量反应方式的复合结果.
- 即使接近正常的NT-proBNP水平也与更差的预后有关,这种关联在各个子组中是一致的,但被BMI修改.
结论:
- NT-proBNP是一种独立且强大的预测HF患者的预后,患者的LVEF已经恢复.
- 在LVEF恢复时的NT-proBNP测量可以指导药物治疗的优化.
- 这种生物标志物有助于实现LVEF恢复的患者的风险分层.
更多相关视频
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
520
08:21Functional Assessment of the Donor Heart During Ex Situ Perfusion: Insights from Pressure-Volume Loops and Surface Echocardiography
Published on: October 11, 2022
2.5K
相关概念视频
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
529
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
529
01:29Heart Failure II: Pathophysiology
699
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
699
01:30Heart Failure VII: Nursing Interventions
408
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
408
01:17Pathophysiology of Heart Failure
2.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.8K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
909
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
909
01:13Sensitivity, Specificity, and Predicted Value
1.2K
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Sensitivity is the...
1.2K